Skip to main content
. 2021 Aug 23;9:713487. doi: 10.3389/fpubh.2021.713487

Table 1.

Top 10 most cited studies on coronavirus disease-2019 (COVID-19).

Title Corresponding authors Journal IF Publication year Total citations Article type
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Wang, JW LANCET 60.39 2020 9,702 Descriptive study
Clinical Characteristics of Coronavirus Disease 2019 in China Zhong, N NEW ENGLAND JOURNAL OF MEDICINE 74.699 2020 5,933 Descriptive study
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Peng, ZY JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 45.54 2020 5,494 Descriptive study
A Novel Coronavirus from Patients with Pneumonia in China, 2019 Wu, GZ NEW ENGLAND JOURNAL OF MEDICINE 74.699 2020 5,189 Retrospective cohort study
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Chen, H LANCET 60.39 2020 5,046 Retrospective cohort study
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Zhang, L LANCET 60.39 2020 4,934 Descriptive study
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Yuen, KY LANCET 60.39 2020 2,423 Descriptive study
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Shang, Y LANCET RESPIRATORY MEDICINE 25.094 2020 1,964 Single-centered, retrospective, observational study
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Sun, ZY JOURNAL OF THROMBOSIS AND HAEMOSTASIS 4.157 2020 1,665 Retrospective cohort study
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Raoult, D INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 4.621 2020 1,475 non-randomized clinical trial